The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes. The findings ...
Nov 25, 2024
0
71
In 2021, a research team led by Prof. Heiko Lickert from Helmholtz Munich discovered the insulin-inhibitory receptor "Inceptor" and its role as a suppressor of the insulin signaling pathway. Now, the researchers have unlocked ...
Nov 25, 2024
0
27
So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you worry about how to handle gatherings where decadent food will be served in abundance.
Nov 25, 2024
0
0
A new study from Northwestern Medicine reveals a troubling rise in severe maternal health issues and birth complications in Illinois from 2016 to 2023, closely linked to increases in chronic health conditions affecting pregnancy, ...
Nov 22, 2024
0
0
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered a key biological reason why obesity increases the risk of type 2 diabetes, and it boils down to size—specifically ...
Nov 22, 2024
0
17
A new study led by researchers at The University of Texas at Austin and Harvard Medical School reveals surprising findings about how babies exposed to gestational diabetes mellitus (GDM) grow during their first year of life.
Nov 19, 2024
0
0
People diagnosed with type 2 diabetes at a younger age are at a higher risk for developing dementia than those diagnosed later in life, according to a study led by researchers at the NYU Rory Meyers College of Nursing. The ...
Nov 19, 2024
0
28
A competitive swimming program developed by University of Queensland researchers for young people with severe cerebral palsy has reversed motor decline associated with the condition.
Nov 19, 2024
0
20
Each year, there are thousands of people waiting for a kidney or liver transplant in the U.S. Some of those transplant candidates are living with diabetes, high blood pressure or obesity, which can sometimes complicate transplant ...
Nov 19, 2024
0
0
More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds.
Nov 19, 2024
0
0
